{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:27:26Z","timestamp":1789331246765,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["No.2020R1C1C100936611"],"award-info":[{"award-number":["No.2020R1C1C100936611"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["No.2018R1D1A1B07049159"],"award-info":[{"award-number":["No.2018R1D1A1B07049159"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["No.2020R1C1C100936611"],"award-info":[{"award-number":["No.2020R1C1C100936611"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The present study aimed to propose a new foetal shielding device for pregnant cancer patients to reduce the foetal dose associated with treatment techniques using multiple gantry angles, such as intensity-modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Three shielding structures were designed to minimise the scattered and leaked radiation from various gantry angles and radiation scattering within the patient. The base-plate part that can be placed on the treatment couch was designed to reduce the scattered and leaked radiation generated at gantry angles located near 180\u00b0. A body shielding part that can cover the lower chest and abdomen was designed, and a neck-shielding structure was added to reduce the internal and external radiation scattering from the treatment area. Evaluation plans were generated to assess the foetal dose reduction by the foetal shielding device in terms of the shielding material thickness, distance from the field edge, and shielding component using the flattened 6 MV photon beam (6MV) and flattening filter-free 6 MV photon beam (6MV-FFF). In addition, the effectiveness of the foetal shielding device was evaluated in a pregnant brain tumour patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The shielding material consisting of three parts was placed on frames composed of four arch shapes with a vertical curved structure, connection bar at the top position, and base plate. Each shielding part resulted in reductions in the radiation dose according to the treatment technique, as the thickness of the shielding material increased and the foetal dose decreased. In addition, a foetal dose reduction of approximately 50% was confirmed at 50\u00a0cm from the field edge by using the designed shielding device in most delivery techniques. In patients, the newly designed shielding structures can effectively eliminate up to about 49% of the foetal dose generated from various gantry angles used in VMAT or IMRT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We designed a foetal shielding device consisting of three parts to effectively reduce the dose delivered to the foetus, and evaluated the device with various treatment techniques for a pregnant patient with brain tumour. The foetal shielding device shielded the scattered\/leaked radiation from the treatment machine, and also effectively reduced internal scattering from the treatment area in the patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01836-z","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:02:27Z","timestamp":1623618147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of a new foetal shielding device for pregnant brain tumour patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Seonghee","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong-Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Beom","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,13]]},"reference":[{"issue":"1","key":"1836_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1118\/1.597525","volume":"22","author":"M Stovall","year":"1995","unstructured":"Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, et al. Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys. 1995;22(1):63\u201382.","journal-title":"Med Phys"},{"issue":"3","key":"1836_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0167-8140(02)00329-8","volume":"66","author":"M Mazonakis","year":"2003","unstructured":"Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin\u2019s disease in early pregnancy: embryo dose measurements. Radiother Oncol. 2003;66(3):333\u20139.","journal-title":"Radiother Oncol"},{"issue":"5","key":"1836_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/acm2.12262","volume":"19","author":"ZE Labby","year":"2018","unstructured":"Labby ZE, Barraclough B, Bayliss RA, Besemer AE, Dunkerley DA, Howard SP. Radiation treatment planning and delivery strategies for a pregnant brain tumor patient. J Appl Clin Med Phys. 2018;19(5):368\u201374.","journal-title":"J Appl Clin Med Phys"},{"key":"1836_CR4","unstructured":"Pregnancy and Medical Radiation. ICRP Publication 84. Ann. 2000;30(1)."},{"issue":"4","key":"1836_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1120\/1.1507921","volume":"3","author":"S Mutic","year":"2002","unstructured":"Mutic S, Esthappan J, Klein EE. Peripheral dose distributions for a linear accelerator equipped with a secondary multileaf collimator and universal wedge. J Appl Clin Med Phys. 2002;3(4):302\u20139.","journal-title":"J Appl Clin Med Phys"},{"issue":"6","key":"1836_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1118\/1.595359","volume":"10","author":"BA Fraass","year":"1983","unstructured":"Fraass BA, van de Geijn J. Peripheral dose from megavolt beams. Med Phys. 1983;10(6):809\u201318.","journal-title":"Med Phys"},{"issue":"5","key":"1836_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0360-3016(96)00254-4","volume":"35","author":"PH Van der Giessen","year":"1996","unstructured":"Van der Giessen PH. A simple and generally applicable method to estimate the peripheral dose in radiation teletherapy with high energy x-rays or gamma radiation. Int J Radiat Oncol Biol Phys. 1996;35(5):1059\u201368.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1836_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1120\/jacmp.v17i5.6135","volume":"17","author":"AM Owrangi","year":"2016","unstructured":"Owrangi AM, Roberts DA, Covington EL, Hayman JA, Masi KM, Lee C, et al. Revisiting fetal dose during radiation therapy: evaluating treatment techniques and a custom shield. J Appl Clin Med Phys. 2016;17(5):34\u201346.","journal-title":"J Appl Clin Med Phys"},{"issue":"5","key":"1836_CR9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.ijrobp.2009.03.033","volume":"76","author":"P Zhang","year":"2010","unstructured":"Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, Mageras G. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys. 2010;76(5):1456\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1836_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.meddos.2012.10.009","volume":"38","author":"MT Studenski","year":"2013","unstructured":"Studenski MT, Bar-Ad V, Siglin J, Cognetti D, Curry J, Tuluc M, et al. Clinical experience transitioning from IMRT to VMAT for head and neck cancer. Med Dosim. 2013;38(2):171\u20135.","journal-title":"Med Dosim"},{"issue":"11","key":"1836_CR11","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1118\/1.3238104","volume":"36","author":"GA Ezzell","year":"2009","unstructured":"Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359\u201373.","journal-title":"Med Phys"},{"issue":"12","key":"1836_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00066-011-2263-1","volume":"187","author":"M Pasler","year":"2011","unstructured":"Pasler M, Wirtz H, Lutterbach J. Impact of gantry rotation time on plan quality and dosimetric verification\u2013volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol. 2011;187(12):812\u20139.","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1836_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-014-1565-4","volume":"120","author":"DP Horowitz","year":"2014","unstructured":"Horowitz DP, Wang TJ, Wuu CS, Feng W, Drassinower D, Lasala A, et al. Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy. J Neuro-Oncol. 2014;120(2):405\u20139.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"1836_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0360-3016(92)90761-6","volume":"23","author":"SY Woo","year":"1992","unstructured":"Woo SY, Fuller LM, Cundiff JH, Bondy ML, Hagemeister FB, McLaughlin P, et al. Radiotherapy during pregnancy for clinical stages IA\u2013IIA Hodgkin\u2019s disease. Int J Radiat Oncol Biol Phys. 1992;23(2):407\u201312.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1836_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1088\/0031-9155\/57\/6\/1733","volume":"57","author":"N Chofor","year":"2012","unstructured":"Chofor N, Harder D, Willborn KC, Poppe B. Internal scatter, the unavoidable major component of the peripheral dose in photon-beam radiotherapy. Phys Med Biol. 2012;57(6):1733.","journal-title":"Phys Med Biol"},{"issue":"883","key":"1836_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1259\/bjr.74.883.740638","volume":"74","author":"N Magne","year":"2001","unstructured":"Magne N, Marcie S, Pignol J, Casagrande F, Lagrange J. Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose. Brit J Radiol. 2001;74(883):638\u201341.","journal-title":"Brit J Radiol"},{"issue":"4","key":"1836_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1440-1673.1992.tb03209.x","volume":"36","author":"SC Ngu","year":"1992","unstructured":"Ngu SC, Duval P, Collins C. Foetal radiation dose in radiotherapy for breast cancer. Australas Radiol. 1992;36(4):321\u20132.","journal-title":"Australas Radiol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01836-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01836-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01836-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:08:34Z","timestamp":1623618514000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01836-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01836-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving a human participants was in accordance with the ethical standards of the institutional research committee. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S Kang, KH Kim, SW Kang, DS Shin, S Lee, JB Chung declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}